BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31624327)

  • 1. Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants.
    Fridman H; Behar DM; Carmi S; Levy-Lahad E
    Genet Med; 2020 Mar; 22(3):646-653. PubMed ID: 31624327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
    Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic disparities among men with prostate cancer undergoing germline testing.
    Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
    Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.
    Punj S; Akkari Y; Huang J; Yang F; Creason A; Pak C; Potter A; Dorschner MO; Nickerson DA; Robertson PD; Jarvik GP; Amendola LM; Schleit J; Simpson DK; Rope AF; Reiss J; Kauffman T; Gilmore MJ; Himes P; Wilfond B; Goddard KAB; Richards CS
    Am J Hum Genet; 2018 Jun; 102(6):1078-1089. PubMed ID: 29754767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing.
    Horton C; Hoang L; Zimmermann H; Young C; Grzybowski J; Durda K; Vuong H; Burks D; Cass A; LaDuca H; Richardson ME; Harrison S; Chao EC; Karam R
    JAMA Oncol; 2024 Feb; 10(2):212-219. PubMed ID: 37924330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic variant-based preconception carrier screening in the Israeli Jewish population.
    Davidov B; Levon A; Volkov H; Orenstein N; Karo R; Fatal Gazit I; Magal N; Basel-Salmon L; Golan Mashiach M
    Clin Genet; 2022 May; 101(5-6):517-529. PubMed ID: 35315053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes.
    Makhnoon S; Chen M; Levin B; Ensinger M; Mattie KD; Grana G; Shete S; Arun BK; Peterson SK
    Cancer; 2022 Oct; 128(20):3709-3717. PubMed ID: 35996941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes.
    Makhnoon S; Levin B; Ensinger M; Mattie K; Volk RJ; Zhao Z; Mendoza T; Shete S; Samiian L; Grana G; Grainger A; Arun B; Shirts BH; Peterson SK
    Cancer Med; 2023 Feb; 12(3):2875-2884. PubMed ID: 36426404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.
    Van Steijvoort E; Chokoshvili D; W Cannon J; Peeters H; Peeraer K; Matthijs G; Borry P
    Hum Reprod Update; 2020 Apr; 26(3):335-355. PubMed ID: 32099997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier screening in the Mexican Jewish community using a pan-ethnic expanded carrier screening NGS panel.
    Morgenstern-Kaplan D; Raijman-Policar J; Majzner-Aronovich S; Aradhya S; Pineda-Alvarez DE; Aguinaga M; García-Vences EE
    Genet Med; 2022 Apr; 24(4):821-830. PubMed ID: 34961661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.
    Shapiro AJ; Kroener L; Quinn MM
    J Assist Reprod Genet; 2021 Apr; 38(4):957-963. PubMed ID: 33501564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritize Variant Reclassification in Pediatric Long QT Syndrome-Time to Revisit.
    Leung HT; Kwok SY; Kwong KY; Shih FY; Tsao S; Chung BH
    Pediatr Cardiol; 2024 Jun; 45(5):1023-1035. PubMed ID: 38565666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of a multidisciplinary team in managing variants of uncertain clinical significance in prenatal genetic diagnosis.
    Diderich KEM; Klapwijk JE; van der Schoot V; van den Born M; Wilke M; Joosten M; Stuurman KE; Hoefsloot LH; Van Opstal D; Brüggenwirth HT; Srebniak MI
    Eur J Med Genet; 2023 Oct; 66(10):104844. PubMed ID: 37709011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
    Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
    Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reclassification of
    Ha HI; Ryu JS; Shim H; Kong SY; Lim MC
    J Gynecol Oncol; 2020 Nov; 31(6):e83. PubMed ID: 33078592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier burden of over 300 diseases in Han Chinese identified by expanded carrier testing of 300 couples using assisted reproductive technology.
    Chen SC; Zhou XY; Li SY; Zhao MM; Huang HF; Jia J; Xu CM
    J Assist Reprod Genet; 2023 Sep; 40(9):2157-2173. PubMed ID: 37450097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
    Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
    JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing ethnicity-based and expanded carrier screening methods at a single fertility center reveals significant differences in carrier rates and carrier couple rates.
    Peyser A; Singer T; Mullin C; Bristow SL; Gamma A; Onel K; Hershlag A
    Genet Med; 2019 Jun; 21(6):1400-1406. PubMed ID: 30327537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.